What Arcadia Biosciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kawakami Mark | Chief Financial Officer | Feb 03 | Open-market buy · P | +700 | $2.49 | +$1.74K | 2,681 |
| Schaefer Thomas J. | Chief Executive Officer | Feb 03 | Open-market buy · P | +700 | $2.49 | +$1.74K | 2,819 |
| Kawakami Mark | Chief Financial Officer | Aug 01 | Open-market buy · P | +700 | $2.06 | +$1.44K | 1,981 |
| Schaefer Thomas J. | Chief Executive Officer | Aug 01 | Open-market buy · P | +700 | $2.06 | +$1.44K | 2,119 |
| Schaefer Thomas J. | Chief Financial Officer | Feb 01 | Open-market buy · P | +700 | $2.06 | +$1.44K | 1,419 |
| Schaefer Thomas J. | Chief Financial Officer | Aug 04 | Open-market buy · P | +649 | $3.67 | +$2.38K | 719 |
| Jacot Stanley Jr | Chief Executive Officer | May 30 | Open-market buy · P | +5,000 | $4.31 | +$21.6K | 5,000 |
| Schaefer Thomas J. | Chief Financial Officer | Feb 01 | Open-market buy · P | +700 | $0.23 | +$161 | 2,800 |
| Haley Pamela | Chief Financial Officer | Aug 01 | Open-market buy · P | +700 | $0.70 | +$490 | 5,088 |
| Haley Pamela | Chief Financial Officer | Aug 03 | Open-market buy · P | +700 | $3.16 | +$2.21K | 2,638 |
| Shultz Randall | Chief Technology Officer | Aug 03 | Open-market buy · P | +700 | $3.16 | +$2.21K | 13,000 |
| Plavan Matthew T | Chief Executive Officer | Aug 03 | Open-market buy · P | +585 | $3.16 | +$1.85K | 14,285 |
| Reiter Sarah | Chief Commercial Officer | Feb 03 | Open-market buy · P | +700 | $1.72 | +$1.2K | 3,800 |
| Haley Pamela | Chief Financial Officer | Feb 03 | Open-market buy · P | +700 | $1.72 | +$1.2K | 1,938 |
| Plavan Matthew T | Chief Executive Officer | Feb 03 | Open-market buy · P | +700 | $1.72 | +$1.2K | 13,700 |
| Reiter Sarah | Chief Commercial Officer | Dec 23 | Open-market buy · P | +900 | $5.95 | +$5.36K | 3,100 |
| Reiter Sarah | Chief Commercial Officer | Nov 19 | Open-market buy · P | +1,000 | $4.52 | +$4.52K | 2,200 |
| Murray Lilian Shackelford | Director | Nov 18 | Open-market buy · P | +5,000 | $4.25 | +$21.3K | 8,524 |
| Plavan Matthew T | Chief Executive Officer | Nov 14 | Open-market buy · P | +1,000 | $4.08 | +$4.08K | 13,000 |
| Plavan Matthew T | Chief Executive Officer | Sep 23 | Open-market buy · P | +2,000 | $5.25 | +$10.5K | 12,000 |
Loading...